ADC Therapeutics SA·4

Jun 3, 5:03 PM ET

Azelby Robert 4

4 · ADC Therapeutics SA · Filed Jun 3, 2026

Research Summary

AI-generated summary of this filing

Updated

ADC Therapeutics (ADCT) Director Robert Azelby Receives RSU Award

What Happened
Robert Azelby, a director of ADC Therapeutics (ADCT), received an annual grant of 45,000 restricted stock units (RSUs) on 2026-06-01 (transaction code A). Separately, on 2026-06-03 the company withheld 12,600 shares to satisfy tax withholding obligations in connection with the vesting of previously granted RSUs (transaction code F), valued at $3.08 per share for a total of $38,808.

Key Details

  • Transaction dates: RSU grant on 2026-06-01; shares withheld for tax on 2026-06-03. Filing date: 2026-06-03. Filing appears timely.
  • Grant: 45,000 RSUs granted at $0.00 (each RSU = contingent right to one share) under the 2019 Equity Incentive Plan.
  • Withholding: 12,600 shares disposed/withheld at $3.08 per share = $38,808 to cover taxes on vesting of earlier RSUs. (Transaction code F = tax withholding.)
  • Vesting terms (footnote): RSUs vest on the earlier of one year from grant or the 2027 Annual Meeting, subject to continued service.
  • Shares owned after the transactions: not specified in the provided excerpt of the Form 4.

Context
The 45,000 RSU grant is an award (not an immediate cash purchase) and represents a contingent future right to receive shares upon vesting. The 12,600-share disposition reflects routine tax withholding when RSUs vest (a cashless withholding), not an open-market sale that necessarily signals sentiment. The withholding amount ($38.8k) is modest.

Insider Transaction Report

Form 4
Period: 2026-06-01
Transactions
  • Award

    Common Shares

    [F1]
    2026-06-01+45,000125,405 total
  • Tax Payment

    Common Shares

    [F2]
    2026-06-03$3.08/sh12,600$38,808112,805 total
Footnotes (2)
  • [F1]Represents the annual grant of restricted stock units ("RSUs") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest on the earlier of (i) one year from the grant date or (ii) the date of the 2027 Annual Meeting of Shareholders, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted.
Signature
/s/ Lisa Kallebo, as Attorney-in-Fact for Robert Azelby|2026-06-03

Documents

1 file
  • 4
    wk-form4_1780520620.xmlPrimary

    FORM 4